Rheumatology Doctors in Manchester, NH Accepting Medicare

7 Rheumatology doctors found. Showing 1 - 7

Jenny Lin, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500

Dr. Douglas F. Marks Jr., M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 87 Mcgregor St, Ste 4100, Manchester, NH 03102 Phone: 603-695-2500    Fax: 603-695-2647

Elise Danielle Mcveigh, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500

Dr. John H Yost, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 87 Mcgregor St, Ste 2200, Manchester, NH 03102 Phone: 603-695-2500

Dr. Naureen Mirza, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 185 Queen City Ave, Manchester, NH 03101 Phone: 603-625-1655

Romy Nicolas Abou Mrad, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500

Irene O Hou, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2550

News Archive

Chelsea prices underwritten public offering of 8.75 million shares of common stock

Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.

Immediate angiography for stroke patients linked to improved recovery, less disability

Immediate angiography, rather than the standard computed tomography (CT scan), reduced stroke treatment time and was linked to improved recovery, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2021.

Endologix, Evasc enter development agreement for balloon expandable stent technology

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has entered into a development agreement and exclusive license with Evasc Medical Systems Corp., for its balloon expandable stent technology. Evasc is a medical device development company located in Vancouver, B.C. The patented stent is made from cobalt chromium and is pre-mounted on an angioplasty balloon catheter for ease-of-use.

Study reports decreasing rates of liver transplantation among HCC patients in the U.S.

Patients with hepatocellular carcinoma (HCC) waiting for a liver transplant in the USA are now significantly less likely to receive a new liver than they were around a decade ago. A nationwide study presented today at The International Liver Congress™ 2018 in Paris, France, has confirmed that patients with HCC on the liver transplant list in the USA were more than 50% less likely to receive a transplant in 2014-2016 than they were in 2005-2007.

Read more Medical News

› Verified 8 days ago